Abstract:A RECENT ANNOUNCEMENT by the American Medical Association that it proposes to assume leadership in the development of a national health policy primarily within the private sector could signal a watershed in the national approach to dealing with the compounding problems the nation faces in health care. That task will not be easy. Policymakers and institutions in both the public and private sectors have long been active in this field, yet no generally acceptable, workable national health policy for the long term has yet emerged. The timing for such a new approach seems particularly auspicious. Americans seem more focused on health and its enhancement now than at any time in their history. For some decades we have been spending more and more for health and health care until now nearly 10 percent of the gross national product is spent for these purposes. Patient care in the United States is generally conceded to be the best in the world. And, significantly, as a nation we seem for the time being at least to have rejected centralized, nationalized, government controlled health care. But all is not well. There is an obvious need for a long-term national health policy that is acceptable and workable, and right now there is a relative vacuum of effective leadership in this field. The opportunity should be seized. The time may come when the nation may have another, perhaps grander, objective than health. It is noteworthy that this health care system has long since passed the point where doctors, hospitals or any other single segment of it (and this includes government) can ever hope to control it without the help and cooperation of the other segments. There are some who still believe that government could of course do so, but the evidence to date is that this is not likely to be the case. So far unilateral government initiatives in health care have fallen far short of what needs to be done and generally seem to have caused more problems than they have solved. Could it be that the health care enterprise is developing into something of a new phenomenon in America-or anywhere else for that matter? Could it be that for the first time we are starting to see the massive fiscal and human dimensions of what can occur when new science and expensive technology are rather quickly developed and put to widespread human use, and the intricate professional, technologic, social, economic and political interdependencies that ensue? For many reasons this seems to be a truly new phenomenon, which has surfaced first in the health field, but is no doubt destined to turn up in other fields as well, when comparable conditions develop. For nearly 40 years the nation has given special attention and special support from both public and private sources to biomedical research, to health professional education and to making the benefits of rapidly accumulating new knowledge and new technology readily available to as many people as possible. As a result a new kind of system of interdependencies has come into being that is as yet poorly understood and certainly does not behave according to the rules for simpler systems. As has been said, if you push the health care system in one place it just bulges somewhere else. It is suggested that this new kind of system is one of interdependencies among relatively independent and autonomous parts. This in turn suggests that if there is to be policy and direction, it will need to be developed internally within the system with involvement and consensus among all or most of the essential autonomous and independent, yet interdependent, parts. The AMA iS to be commended for its proposed approach to developing a national health policy. It plans to involve "such organizations as specialty societies, the American Hospital Association, Blue Cross-Blue Shield, the American Dental Association, the American Nurses Association, the National Medical Association, The Health Insurance Association of America, representatives of the business community such as Chambers of Commerce and The Business Round Table, representa-

3-(Methylthio)Propionic Acid from Bacillus thuringiensis Berliner Exhibits High Nematicidal Activity against the Root Knot Nematode Meloidogyne incognita (Kofoid and White) Chitwood

The AMA and a National Health Policy.

Nematicidal Volatiles from Bacillus atrophaeus GBSC56 Promote Growth and Stimulate Induced Systemic Resistance in Tomato against Meloidogyne incognita

Optimization of Seed Treatment Dose of the Cucumber Endophytic Chaetomium Ch1001 Strain for Biological Control of Root Knot Nematode Meloidogyne incognita

The Biocontrol Functions of Bacillus velezensis Strain Bv-25 Against Meloidogyne incognita

Volatile organic compounds from Paenibacillus polymyxa KM2501-1 control Meloidogyne incognita by multiple strategies

Bacillus thuringiensis Cry5, Cry21, App6 and Xpp55 proteins to control Meloidogyne javanica and M. incognita

Volatile Organic Compounds of Bacillus velezensis GJ-7 against Meloidogyne hapla through Multiple Prevention and Control Modes

Suppression of Meloidogyne Javanica by Antagonistic and Plant Growth-Promoting Rhizobacteria

Volatile organic compounds released from entomopathogenic nematode-infected insect cadavers for the biocontrol of Meloidogyne incognita

Synthesis and Nematicidal Activities of 1,2,3-Benzotriazin-4-one Derivatives against Meloidogyne incognita

High killing rate of nematode and promotion of rice growth by synthetic volatiles from Bacillus strains due to enhanced oxidative stress response

Biocontrol efficacy of Bacillus velezensis strain YS-AT-DS1 against the root-knot nematode Meloidogyne incognita in tomato plants

Design, synthesis and nematicidal activitives of trifluorobutene amide derivatives against Meloidogyne incognita

Bacillus Cereus X5 Enhanced Bio-Organic Fertilizers Effectively Control Root-Knot Nematodes (meloidogyne Sp.)

Biocontrol activity and potential mechanism of Bacillus cereus G5 against Meloidogyne graminicola

Role of bacterial antagonists of fungal pathogens, Bacillus thuringiensis KYC and Bacillus velezensis CE 100 in control of root-knot nematode, Meloidogyne incognita and subsequent growth promotion of tomato

Potential Nematicidal Properties of Silver Boron Nanoparticles: Synthesis, Characterization, In Vitro and In Vivo Root-Knot Nematode (Meloidogyne incognita) Treatments

A combination of plant-based compounds and extracts acts nematicidal and induces resistance against Meloidogyne incognita in tomato

Bioactive Volatiles from an Endophytic Daldinia cf. concentrica Isolate Affect the Viability of the Plant Parasitic Nematode Meloidogyne javanica

What standards and terms of employment should respiratory practitioners with a special interest expect from an employing organisation?